Erin J. Stringfellow

Erin J. Stringfellow is a prominent academic figure at Harvard University, where they contribute to the Public Health through intensive research in Opioid Use Disorder, Substance Abuse Treatment, Overdose Prevention, Homelessness, Social Determinants, Fentanyl, Public Health Policy, Health Equity. A representative example of their recent contribution is the study titled "Temporal and spatial trends of fentanyl co-occurrence in the illicit drug supply in the United States: a serial cross-sectional analysis", which offers critical insights into the dynamics of Opioid Use Disorder and Substance Abuse Treatment. Additional work such as "The association between buprenorphine doses above 16 milligrams and treatment retention in a multi‐payer national sample in the United States, 2014 to 2021" further demonstrates their commitment to advancing knowledge in this domain.